Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Bill Shufelt, Co-Founder and CEO, Athletic Brewing Co
The takeaway from these studies: Obesity is a chronic condition and without ongoing treatment (whether medication, surgery, or intensive behavioral support), biology will try to pull weight back up
However, most pivotal GLP-1 trials excluded acutely ill or surgical patients, leaving important gaps in inpatient guidance
Hepatic triacylglycerol accumulation and insulin resistance
But it could help clinicians optimize therapy for patients who have trouble affording the drugs or who struggle with gastrointestinal issues or other side effects, she says
Cover image source: Fernanda/stock.adobe.com Related Articles and Resources WHAT PROBLEM DOES THIS STUDY ADDRESS
